Blog
California Resources Corp. Surges on Better-Than-Expected Q3 Results
Shares of California Resources (NYSE: CRC) jumped on Tuesday and were up 10.4% at 11:00 a.m. EST. That's its second double-digit jump this week, this time fueled by the oil producer's....
Why Bed Bath & Beyond Stock Dropped 15% in October
Shares of Bed Bath & Beyond (NASDAQ: BBBY) fell 15% last month, according to data from S&P Global Market Intelligence, as the home-goods retailer continued to reel from a weak earnings....
Why CRISPR Therapeutics AG Stock Edged Higher in October
After a turbulent September, genome-editing company CRISPR Therapeutics AG (NASDAQ: CRSP) saw its shares gain 8% last month, according to S&P Global Market Intelligence. Although the company....
Why MuleSoft, Inc. Stock Gained 16.1% in October
Shares of MuleSoft, Inc. (NYSE: MULE) gained 16.1% in October, according to data provided by S&P Global Market Intelligence. The company's stock climbed on favorable ratings coverage and held....
A Trifecta of Financial World Changes That Favor the Status Quo
Industry Focus: Financials edition host Michael Douglass and Fool.com contributor Matt Frankel look at three big financial news stories from the last week.They discuss what investors should expect....
3 Things to Look For When Plug Power Reports Q3 Earnings
Expected to report third-quarter earnings on Nov. 8, Plug Power (NASDAQ: PLUG), a leader in fuel cell solutions, believes it will be starting off the second half of the year with a bang. In a....
Why Shares of Polaris Industries Inc. Popped in October
Shares of ATV and snowmobile maker Polaris Industries Inc. (NYSE: PII) jumped 13.2% in October, according to data provided by S&P Global Market Intelligence, after reporting a surprisingly....
HollyFrontier's Eearnings More Than Double on Friendly Refining Market
After slogging through a challenging 2016, HollyFrontier's (NYSE: HFC) results in 2017 have been a stark improvement. Not only did the company's refining business produce outstanding results, the....
Better Buy: Himax Technologies Inc. vs. NVIDIA
Early November should prove interesting for followers of both Himax Technologies (NASDAQ: HIMX) and semiconductor industry darling NVIDIA (NASDAQ: NVDA). Both will announce quarterly earnings on....
J.C. Penney Stock: Value Trap or Value Play?
J.C. Penney (NYSE: J.C.P) shares recently plunged to an all-time low after the department store chain slashed its third-quarter outlook ahead of its earnings report due on Nov. 10. The retailer....
Hi-Crush Partners Turns in Great Q3 and Reinstates Distribution
If you were one of the investors that waited for Hi-Crush Partners (NYSE: HCLP) to turn around, your patience has been rewarded: The company's results have improved markedly over the past few....
Howard Hughes Corp.'s Earnings Slip Due to the Timing of Condo Sales
Howard Hughes (NYSE: HHC) is in a bit of a transitional phase right now because the company is wrapping up construction on the first phase of its condo development in Hawaii, which had driven....
The Priceline Group Inc. (PCLN) Q3 2017 Earnings Conference Call Transcript
Image source: The Motley Fool.The Priceline Group, Inc. (NASDAQ: PCLN)Q3 2017 Earnings Conference CallNov. 6, 2017, 4:30 p.m. ETOperatorContinue readingSource: Fool.com
Why This Iron Ore Miner's Stock Fell 16.6% in October
Shares of Cleveland-Cliffs Inc (NYSE: CLF) fell a painful 16.6% last month. Although there were declines across the entire month, the biggest drop came after the iron ore miner reported earnings....
Twilio Stock Has a Lot to Prove on Wednesday
It's time for Twilio Inc. (NYSE: TWLO) to step up with its latest financial results. The leading provider of in-app communications solutions posts its third-quarter results after Wednesday's....
Sysco Corporation (SYY) Q1 2018 Earnings Conference Call Transcript
Image source: The Motley Fool.Sysco Corporation. (NYSE: SYY)Q1 2018 Earnings Conference CallNov. 6, 2017, 10:00 a.m. ETOperatorContinue readingSource: Fool.com
Here's Why Regeneron Pharmaceuticals Inc. Slipped 10% in October
Shares of Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) took a hit last month as investors adjusted their outlook for a recently launched eczema drug with megablockbuster potential. According to....
Why Celldex Therapeutics Stock Crumbled in October
Shares of the clinical-stage biotech Celldex Therapeutics (NASDAQ: CLDX) fell by 14.7% in October, according to S&P Global Market Intelligence. The good news -- if you can call it that -- is....
New Technologies Help Push RigNet Inc.'s Revenue Higher
RigNet (NASDAQ: RNET) continued to battle a sluggish offshore drilling market in the third quarter, which weighed on results. However, the company has been working to overcome those weak market....
What You Need to Know to Understand Newmont Mining's Dividend History
Newmont Mining Corp (NYSE: NEM) investors were treated to a 50% dividend increase in September of 2017, three times the payment investors received in the third quarter of 2016. You might think....
Why Shares of Fitbit, Inc. Plunged in October
Shares of activity tracker company Fitbit, Inc. (NYSE: FIT) plunged 11.8% in October, according to data provided by S&P Global Market Intelligence, after an unimpressive product introduction.....
Here's Why Disney Would Want a Big Piece of Fox
Walt Disney (NYSE: DIS) has built its recent success on the back of the intellectual property (IP) it owns. Since the company spent $7.4 billion buying Pixar, and $4 billion each for Marvel and....
Growth Slows at Zayo Group Holdings
Businesses across every sector of the economy have needed to modernize their information technology capabilities in order to keep up with their peers, and the companies that help to connect....
Natural Disasters Hit Douglas Dynamics
Douglas Dynamics (NYSE: PLOW) has worked hard to broaden out its business, going beyond its traditional winter-oriented snowplows and ice-fighting equipment to incorporate all-season equipment to....
Allergan Keeps Heading Lower. Is It Time to Buy?
Allergan's (NYSE: AGN) stock slid by double digits for the third straight month in October. So after dropping by another 13.5% last month, Allergan's stock has now lost around 30% of its value....